Eugia Pharma Specialities Profile
Key Indicators
- Authorised Capital ₹ 800.00 Cr
- Paid Up Capital ₹ 621.01 Cr
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 724.00 Cr
- Revenue Growth 55.49%
- Profit Growth 198.90%
- Ebitda 113.19%
- Net Worth 68.12%
- Total Assets 7.53%
About Eugia Pharma Specialities
Eugia Pharma Specialities Limited (EPSL) is a leading Public Limited Indian Non-Government Company incorporated in India on 17 April 2013 and has a history of 11 years and ten months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 800.00 Cr and a paid-up capital of Rs 621.01 Cr.
The company has closed loans amounting to ₹724.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Eugia Pharma Specialities Limited India are Venkat Kupireddy as Company Secretary, Yugandhar Puvvala as Ceo, and Vallamkondu Kumar as Cfo. Veerayya Kosaraju, Santhanam Subramanian, Sundari Pisupati, and Three other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24297TG2013PLC087048
- Company No.
087048
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2013
- Date of AGM
22 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Eugia Pharma Specialities?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkat Kupireddy  | Company Secretary | 10-Jun-2019 | Current |
| Yugandhar Puvvala | CEO | 27-Dec-2021 | Current |
| Vallamkondu Kumar | CFO | 21-Feb-2024 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sundari Pisupati | Director | 01-Dec-2021 | Current |
| Ragunathan Kannan | Director | 01-Dec-2021 | Current |
| Veerayya Kosaraju | Director | 01-Dec-2021 | Current |
| Santhanam Subramanian | Director | 01-Oct-2021 | Current |
| Madan Mettu | Director | 17-Apr-2013 | Current |
| Yugandhar Puvvala | Director and Ceo | 01-Dec-2021 | Current |
Financial Performance of Eugia Pharma Specialities.
Eugia Pharma Specialities Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 55.49% increase. The company also saw a substantial improvement in profitability, with a 198.9% increase in profit. The company's net worth Soared by an impressive increase of 68.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eugia Pharma Specialities?
In 2024, Eugia Pharma Specialities had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pravesha Industries Private LimitedMadan Mettu is a mutual person
My Home Industries Private LimitedVeerayya Kosaraju is a mutual person
Genome FoundationVeerayya Kosaraju is a mutual person
Sathguru Management Consultants Pvt LtdRagunathan Kannan is a mutual person
Divi's Laboratories LimitedVeerayya Kosaraju is a mutual person
Fernandez FoundationRagunathan Kannan is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹724.00 Cr
Charges Breakdown by Lending Institutions
- Others : 605.00 Cr
- Export Import Bank Of India : 119.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2019 | Others | ₹105.00 Cr | Satisfied |
| 06 Jul 2017 | Others | ₹500.00 Cr | Satisfied |
| 24 Feb 2014 | Export Import Bank Of India | ₹119.00 Cr | Satisfied |
How Many Employees Work at Eugia Pharma Specialities?
Eugia Pharma Specialities has a workforce of 2763 employees as of Feb 14, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eugia Pharma Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eugia Pharma Specialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Eugia Pharma Specialities
Recent activity within the organization
- Annual General Meeting
Eugia Pharma Specialities Limited last Annual general meeting of members was held on 22 Jul 2024 as per latest MCA records.
- Balance Sheet
Eugia Pharma Specialities Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Vallamkondu Aravind Kumar was appointed as a Cfo was appointed as a Cfo on 21 Feb 2024 & has been associated with this company since 1 year 9 days .
- Charges
A charge registered on 27 Sep 2019 via Charge ID 100295568 with Others was fully satisfied on 04 Mar 2022.
- Director Appointment
Yugandhar Puvvala was appointed as a Ceo was appointed as a Ceo on 27 Dec 2021 & has been associated with this company since 3 years 2 months .
- Director Appointment
Veerayya Chowdary Kosaraju was appointed as a Director was appointed as a Director on 01 Dec 2021 & has been associated with this company since 3 years 3 months .
Recent News, Updates & Announcement
Frequently asked questions
What is the Incorporation or founding date of Eugia Pharma Specialities Limited?
Eugia Pharma Specialities Limited was incorporated on 17 Apr 2013.
What is authorized share capital and paid-up capital of Eugia Pharma Specialities Limited?
The authorized share capital of Eugia Pharma Specialities Limited is ₹ 800.00 Cr and paid-up capital is ₹ 621.01 Cr.
Who are the current board members & directors of Eugia Pharma Specialities Limited?
Currently 9 directors are associated with Eugia Pharma Specialities Limited.
- Venkat Reddy Kupireddy
- Veerayya Chowdary Kosaraju
- Santhanam Subramanian
- Sundari Raviprasad Pisupati
- Madan Mohan Reddy Mettu
- Ragunathan Kannan
- Yugandhar Puvvala
- Yugandhar Puvvala
- Vallamkondu Aravind Kumar
What is the registered address of Eugia Pharma Specialities Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Eugia Pharma Specialities Limited is Plot No.2 Maitrivihar, India, Ameerpet, Telangana, 500038.
What is the corporate identification number (CIN) and company number of Eugia Pharma Specialities Limited?
The corporate identification number (CIN) of Eugia Pharma Specialities Limited is U24297TG2013PLC087048 and the company number is 087048 as per Ministry of Corporate Affairs (MCA).
What is the official website of Eugia Pharma Specialities Limited?
The Official website of Eugia Pharma Specialities Limited is https://www.eugiapharma.com
What has been the recent revenue trend for Eugia Pharma Specialities Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Eugia Pharma Specialities Limited has risen by 55.49%.
How many employees does Eugia Pharma Specialities Limited currently have?
As Per 2024 financial reports, 2763 employees are currently employed by Eugia Pharma Specialities Limited.
What change has been observed in the net worth of Eugia Pharma Specialities Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Eugia Pharma Specialities Limited has experienced an upsurge of 68.12%.
When was the last Balance Sheet of Eugia Pharma Specialities Limited filed with the ROC?
The most recent Balance Sheet for Eugia Pharma Specialities Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
Bharadwaj VenkatavaraghavanDirector
Vivek KaushikAlternate Director and Alternate Director
Vinod AervaDirector
Vijay VasireddyDirector
Vijay NatarajanWholetime Director
Sanjeev DaniDirectorGN
Govindarajan NarayananDirectorSS
Sambasiva SanguAlternate Director
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Mumbai, Maharashtra, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India